PL3415535T3
Improved nanobodies tm for the treatment of aggregation-mediated disorders
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 19 May 2026, 0.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
68 members in 28 offices
Priority claims16
| Document | Office | Kind | Date |
|---|---|---|---|
| 68347405 | United States of America | P | |
| 68347405 | United States of America | P | |
| 06776035 | European Patent Office (EPO) | A | |
| 06776035 | European Patent Office (EPO) | A | |
| 12151893 | European Patent Office (EPO) | A | |
| 12151893 | European Patent Office (EPO) | A | |
| 18186517 | European Patent Office (EPO) | A | |
| 2006004773 | European Patent Office (EPO) | W | |
| 2006004773 | European Patent Office (EPO) | W | |
| 181865171 | – | – | – |
| 68347405P | – | – | – |
| EP20060776035 | – | – | – |
| EP20120151893 | – | – | – |
| EP20180186517 | – | – | – |
| US20050683474P | – | – | – |
| WO2006EP04773 | – | – | – |
Members68
| Document | Office | Kind | |
|---|---|---|---|
| AU2006249090A1 | Australia | A1 | |
| AU2006249090A8 | Australia | A8 | |
| CA2608873A1 | Canada | A1 | |
| CA2960105A1 | Canada | A1 | |
| WO2006122825A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2006122825A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO2006122825A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20190279A1 | Norway | A1 | |
| MX2007014564A | Mexico | A | |
| IL187168A0 | Israel | A0 | |
| IL187168D0 | Israel | D0 | |
| NO20076475L | Norway | L | |
| KR20080023301A | Republic of Korea | A | |
| CN101213214A | China | A | |
| ZA200709570B | South Africa | B | |
| JP2008539775A | Japan | A | |
| EP2007814A2 | European Patent Office (EPO) | A2 | |
| RU2007147381A | Russian Federation | A | |
| NZ563392A | New Zealand | A | |
| US2010022452A1 | United States of America | A1 | |
| BRPI0609797A2 | Brazil | A2 | |
| US7807162B2 | United States of America | B2 | |
| IL208607A0 | Israel | A0 | |
| IL208607D0 | Israel | D0 | |
| US2010330084A1 | United States of America | A1 | |
| RU2433139C2 | Russian Federation | C2 | |
| EP2444424A1 | European Patent Office (EPO) | A1 | |
| JP4986997B2 | Japan | B2 | |
| AU2006249090B2 | Australia | B2 | |
| US8372398B2 | United States of America | B2 | |
| US2013136736A1 | United States of America | A1 | |
| CN101213214B | China | B | |
| KR101414438B1 | Republic of Korea | B1 | |
| IL187168A | Israel | A | |
| CA2608873C | Canada | C | |
| EP3243839A1 | European Patent Office (EPO) | A1 | |
| BRPI0609797B1 | Brazil | B1 | |
| EP2444424B1 | European Patent Office (EPO) | B1 | |
| LT2444424T | Lithuania | T | |
| SI2444424T1 | Slovenia | T1 | |
| PT2444424T | Portugal | T | |
| TR2018015552T4 | Türkiye | T4 | |
| TR201815552T4 | Türkiye | T4 | |
| DK2444424T3 | Denmark | T3 | |
| EP3415535A1 | European Patent Office (EPO) | A1 | |
| ES2694247T3 | Spain | T3 | |
| PL2444424T3 | Poland | T3 | |
| LUC00099I1 | Luxembourg | I1 | |
| NL300966I1 | Netherlands (Kingdom of the) | I1 | |
| HUE039846T2 | Hungary | T2 | |
| FR19C1005I1 | France | I1 | |
| HUS1900005I1 | Hungary | I1 | |
| NL300966I2 | Netherlands (Kingdom of the) | I2 | |
| LUC00099I2 | Luxembourg | I2 | |
| FR19C1005I2 | France | I2 | |
| CY1122579T1 | Cyprus | T1 | |
| CY2019006I1 | Cyprus | I1 | |
| CY2019006I2 | Cyprus | I2 | |
| LTC2444424I2 | Lithuania | I2 | |
| LTPA2019504I1 | Lithuania | I1 | |
| EP3415535B1 | European Patent Office (EPO) | B1 | |
| NO345342B1 | Norway | B1 | |
| PT3415535T | Portugal | T | |
| NO2021020I1 | Norway | I1 | |
| BRPI0609797B8 | Brazil | B8 | |
| PL3415535T3This record | Poland | T3 | |
| ES2852423T3 | Spain | T3 | |
| BE2019C503I2 | Belgium | I2 |
Numbers
- Publication
- 3415535
- Publication, DOCDB
- 3415535
- Publication, EPODOC
- PL3415535T
- Application
- 18186517
- Application, DOCDB
- 18186517
- Application, EPODOC
- PL20180186517T
Titles2
- English
- IMPROVED NANOBODIES TM FOR THE TREATMENT OF AGGREGATION-MEDIATED DISORDERS
- Polish
- Ulepszone Nanociała TM do leczenia zaburzeń, w których pośredniczy agregacja
Classification
- CPC, 17
- C07K16/36
- A61K38/36
- A61K2039/505
- C07K2317/22
- C07K2317/24
- C07K2317/569
- C07K2317/92
- C07K2317/76
- A61P41/00
- A61P43/00
- A61P7/00
- A61P7/02
- A61P9/10
- A61P9/14
- Y02A50/30
- B82Y5/00
- C07K14/47
- IPC, 3
- C07K16 36
- A61K38 36
- A61K39 00